|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: Yahoo FinanceGet free summary analysis Novartis AG reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Novartis AG – Johnson & Johnson (JNJ-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 12,462.71 million, Net Earnings of USD 2,015.70 million. Gross ... Read more (Read more...)
Citigroup on Thursday initiated coverage of electric car maker Tesla at neutral/high risk. Analysts also upgraded PC and printer maker HP and athletic apparel vendor Nike.
Shares of Pfizer (PFE) have gained 5.1% since closing at $32 on June 7, and the stock even looks like it had been making a run for the top of its recent range. In fact, they call themselves "long-time supporters" of the company, and see "opportunities for upside over the long term." So why are they downgrading Pfizer?